Key result
The Hypertension Disease Management Program is linked to ~6 mm Hg lower systolic BP.
Why the study?
Does the Hypertension Disease Management Program improve blood pressure, health behaviors, and medical service utilization in patients with hypertension?
Observational (n=1,260)
Does the Hypertension Disease Management Program improve blood pressure, health behaviors, and medical service utilization in patients with hypertension?
A structured hypertension disease management program effectively improves patient lifestyle behaviors and reduces blood pressure, though it may not yield short-term reductions in medical service utilization.
Answers are grounded in this paper and cite their sources.
Supports hypertension disease management for BP reduction; leaves open effects on behaviors and utilization pending RCTs.
This study evaluated how the Hypertension Disease Management Program (HDMP) affects patient's blood pressure, knowledge, health behaviors, and use of medical services. Evaluation was performed by 2 measures, which were before and after comparison within the management group (n = 210) and comparison between the management group and control group (n = 1050) in 2005. Systolic and diastolic blood pressure of management group significantly decreased from 137.5 and 86.0 mm Hg to 131.2 and 83.8 mm Hg (P < .001, P < .01), respectively. Dieting, snack control, consumption of low-sodium meals, low-cholesterol meals, and fruits or vegetables, regular checking of blood pressure, and stress management techniques significantly increased after HDMP. However, there was no significant difference in the use of medical service between the disease management group and the control group. This study showed that the HDMP improved lifestyle and reduced blood pressure on the disease management group, but changed neither medical costs nor use of medical services. Long-term evaluation should be performed to determine if the HDMP reduce medical costs and use of medical services.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2010) conducted an observational in Hypertension (n=1,260). Hypertension Disease Management Program (HDMP) vs. Control group was evaluated on Systolic and diastolic blood pressure (p=<.001). The Hypertension Disease Management Program significantly reduced systolic blood pressure from 137.5 to 131.2 mm Hg (P<.001) and diastolic blood pressure from 86.0 to 83.8 mm Hg (P<.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: